| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.331 | 4.431 | 4.066 | 6.776 | 7.064 | 8.971 | 10.088 | 10.423 | 11.470 |
| Total Income - EUR | - | 1.331 | 4.433 | 4.066 | 6.776 | 7.064 | 8.971 | 10.091 | 10.423 | 11.472 |
| Total Expenses - EUR | - | 348 | 1.777 | 1.106 | 3.173 | 6.408 | 6.197 | 7.181 | 5.840 | 13.162 |
| Gross Profit/Loss - EUR | - | 983 | 2.656 | 2.959 | 3.603 | 657 | 2.774 | 2.910 | 4.583 | -1.690 |
| Net Profit/Loss - EUR | - | 943 | 2.523 | 2.837 | 3.400 | 445 | 2.505 | 2.662 | 3.745 | -1.878 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neuro. Emg S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 2.092 | 12.740 | 10.043 | 5.627 | 2.127 | 265 | 1.165 |
| Current Assets | - | 1.005 | 2.635 | 3.331 | 713 | 1.912 | 3.727 | 588 | 407 | 2.141 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 1.051 | 0 | 0 | 0 | 0 | 0 | 0 | 1.161 |
| Cash | - | 1.005 | 1.584 | 3.331 | 713 | 1.912 | 3.727 | 588 | 407 | 980 |
| Shareholders Funds | - | 45 | 2.567 | 1.059 | 4.439 | 4.799 | 1.878 | 49 | 49 | -1.830 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 961 | 67 | 4.363 | 9.015 | 7.155 | 7.476 | 2.667 | 623 | 5.136 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro. Emg S.r.l.